Dramatic changes the social, demographic and economic context in which the pharmaceutical industry pharma operates is changing dramatically. Marketing the future, the third in a series of papers on the future of the pharmaceutical industry published by pricewaterhousecoopers. These compounds are typically aggregators, reactive compounds andor panassay interference compounds pains, and many of them are frequent hitters. This paper explores how the industrys approach to sales and marketing will change as it moves towards providing products and service to improve the health of patients, whilst clearly demonstrating value for money. Creating a marketing and sales function that is fit for the future. The major pharma companies rightly promote themselves as being researchbased. Strategies to improve interactions with key physicians. Research has shown that pharma mergers reduce innovation. The pharma supply chain needs a radical overhaul, and pwc predicts that it will undergo three key changes over the next decade.
Pharma automation markets 2020 development of pharma automation hardware, software and services markets until 2020 compound annual world market growth rates of automation products and services for the pharmaceutical industry. The future success of todays market leaders will be determined by how they react to these changes. Pdf mergers and acquisitions in indian pharmaceutical. The future of pharma marketing one to five years out posted august 22, 2017 in whitepapers with the monumental shifts in healthcare and the pharmaceutical industry expected to come from washington, d. In this generation more pharmaceutical companies are using social media sites or ecommerce sites as a medium for. Pfizer has already started to apply its commercial optimizer model in specialty businesses. Mar 28, 2019 assay interference caused by small molecules continues to pose significant challenges for early drug discovery. Contract pharma pharmaceutical and biopharmaceutical. We built a model to estimate market growth, considering four demand drivers. Pharmas fully integrated business model is under huge pressure and by 2020 no pharma company will be able to profit alone. Pharma operates in a constantly evolving landscape yet many companies persist with skillscompetency surveys of their people and processes which define their capability level in terms of the last 12 months to today. Extract from the pricewaterhousecoopers report pharma 2020. It also provides leaders with key questions and actions to consider in the year ahead.
In this changing environment, we can observe four distinct strategic archetypes emerging. With marketing a consistent issue for pharma, one which will likely continue to grow, getting personal is the only option for future success. With new regulations, a growing care team, and aggressive merger and acquisition strategies, the pharmaceutical industry looks radically different than it did a few years ago, and the evolution is set to continue. Preparing for biopharma marketing in 2020 and beyond who. The future healthcare and pharma companies, especially larger. Excipients spi pharma, one of our road to cphi milano sponsors discuss how they are preparing to face the future of healthcare. Welcome to the deloitte centre for health solutions report pharma and the connected patient. Investment in data capabilities is set to increase for many of them. The pharmaceutical industry and the future of drug development. This publication highlights how pharma s fully integrated business models may not be the best option for the. Pdf the urge to merge in the pharmaceutical industry. Products practice undertook a research project to examine the future of the indian pharmaceuticals market over the next decade.
Brimming with inspirational content, the latest marketing and sales trends, and actionable strategies to leverage digital opportunities so you can deliver a topnotch patient experience, future pharma is the eyes and ears of pharma commercialization. By preparing for this future now, organizations not only reduce. Tisha oehmen july 17, 2012 6 comments its hard as marketers to get far enough out of the day to day to observe trends materializing to influence our ability to do our jobs, much less think about marketing in 2020. Nov 11, 2019 20 stocks that could double your money in 2020 big gains could be just a click of the buy button away. Pdf innovative strategy for the pharma of the future. Publicis sam welch on global shifts in the industry the changes within the pharmaceutical industry show no signs of abating as financial pressures whether from the decline of the traditional blockbuster or the rise of costcontainment measures press down on companies. Pharma medical affairs 2020 and beyond matthias evers edd flemngi arnab ghatak jan hartmann arf nai thoo ron piervincenzi. Spi pharma the future of healthcare how is spi pharma preparing to face the future of healthcare. Aug 22, 2017 home the future of pharma marketing one to five years out posted august 22, 2017 in whitepapers with the monumental shifts in healthcare and the pharmaceutical industry expected to come from washington, d. Pharma companies face a number of key decisions that will determine their success and even survival in a.
Our predictions lean more towards an optimistic view of the future. These changes mean any future product needs to have a market access strategy built into it during its initial stages of development. The pharmaceutical sector is no exception, even though companies are in the early. India pharma 2020 propelling access and acceptance, realising true potential. What trends do you currently see in pharmaceutical marketing that will impact the way marketers reach patients, physicians and other stakeholders in. In order to make the most of these future growth opportunities, the industry must fundamentally change the way. The future of pharma marketing one to five years out pm360. In addition, healthcare and pharma companies are 9% more likely than their peers in other sectors to say that datadriven marketing is a topthree strategic priority in 2017. The pharmaceuticalbiotechnology industry has become increasingly concentrated over the past two decades. Healthcare and life sciences predictions 2020 a bold future. Supplying the future 1 table of contents introduction 2 the times they are achangin 3 new product types live licensing the increasing emphasis on outcomes. Pdf mergers and acquisitions in indian pharmaceutical industry. It will become a means of market differentiation and source of economic value. Recent trends in specialty pharma business model sciencedirect.
The future healthcare and pharma companies, especially larger ones, will focus on the. The report is furnished to the recipient for information purposes only. We beiel ve that at least three new, stronger forces wl eli merge that wl gli reatly alter the healthcare landscape. It will fragment, with different models for different product types and patient segments. Digital transformation for biotech and pharma companies bcg. However, neither the report, nor the project as a whole would have been possible to do without the. There are many problems facing the pharma business when it comes to marketing. With solutions that have been used by providers for more than 25 years, merge healthcare, now part of ibm watson health, is a leading provider of medical imaging and information management software and. In a dissenting statement pdf, commissioner rohit chopra, a known consumer advocate, challenged the. With the monumental shifts in healthcare and the pharmaceutical industry expected to come from washington, d. In the future, leading the way with a multidimensional, patientcentric approach to the drug pipeline will allow for increased profits and improved health outcomes. Marketing the future is the third in this series of papers on the future of the pharmaceutical industry published by.
With solutions that have been used by providers for more than 25 years, merge healthcare, now part of ibm watson health, is a leading provider of medical imaging and information management software and services. Pharma 2020 marketing the future information packaging. Anon, pharma 2020, the vision, pricewaterhousecoopers report, 2010. Propelling access and acceptance, realising true potential vikas bhadoria ankur bhajanka kaustubh chakraborty palash mitra. Each recipient should conduct its own investigation and analysis of. Build marketing and sales functions that are fit for the future. Create organisational cultures that are suitable for marketing specialist healthcare packages.
The future for pharma marketing is personal pharmaphorum. February 2020 pharma and medtech companies around the world. A recent report puts forward two business models that are likely to emerge as companies prepare for this future. The threshold of innovation in 2010, the pharmaceutical industry pharma will not only make white powders. The definition of value will be much broader and will expand as the types of healthcare stakeholders who demand a demonstration of value increase. Challenging business models is the fourth paper in the pharma 2020 series on the future of the pharmaceutical industry to be published by pricewaterhousecoopers. The 2020 deloitte global life sciences outlook takes a detailed look at the factors driving these changes and outlines suggestions on how biopharma and medtech organizations can aspire to find real value for themselves and their shareholders in the coming year. Creating the workforce of the future april 2020 reskilling employees to address talent gaps can help a company retain the bulk of its operations workers and empower them to take. Mergers and acquisitions in the pharmaceutical industry. Jul 17, 2012 in the future, marketing strategy will be heavily influenced by new trends for marketing here. The fundamental challenges on the romanian pharmaceutical market are another key objective of our paper. Publicis sam welch on global shifts in the industry the changes within the pharmaceutical industry show no signs of abating as financial pressures whether from the decline of the traditional blockbuster or the rise of costcontainment measures.
Dec 19, 2012 4recognising the interdependence of the pharmaceutical andhealthcare value chains 8investing in the development of medicines the market wants to buy 10forming a web of alliances to offer supporting services 12developing a plan for marketing and selling specialist therapies creating a culture that is suitable for marketing specialist. Preparing for biopharma marketing in 2020 and beyond who is the marketer of the future. Our contract services directory contains listings for all of your outsourcing needs, covering manufacturing, packaging, formulation, clinical trials, equipment, ingredients and more. Pharma news, views and analysis of healthcare in a rapidly changing world.
By 2020 the current role of the pharmaceutical industrys sales and marketing workforce will be replaced by a new model as the industry shifts from a massmarket to a targetmarket approach to increase revenue. Pdf this case study focuses on the giant glaxo wellcome and smithkline beecham. Drivers of change analyses the operational challenges marketers face and examines solutions that will underpin solid, integrated marketing strategies. Jan 01, 2016 there are many problems facing the pharma business when it comes to marketing. In 1985 the ten largest firms accounted for about 20 percent of worldwide sales, whereas in 2002 the ten largest firms accounted for 48 percent of sales.
Innovations through mergers and acquisitions in the pharmaceutical sector. Has direct to consumer marketing in pharma had its day. Pharma automation markets 2020 intechno consulting. Presently, with pharmas perception of safe risks, engaging in cautious analytics eventually results in bad risks. Excipients spi pharma, one of our road to cphi milano sponsors discuss how they are preparing to face the future of. As author of the report, i take full responsibility for it, including any mistakes. Nov 23, 2017 with marketing a consistent issue for pharma, one which will likely continue to grow, getting personal is the only option for future success. Technology is increasingly a strategic topic for biopharma leaders, as digital and data analytics are exploited for competitive advantage. The report draws on the detailed and incisive insights of 7 marketing professionals working in leading companies in europe and the us.
The pharma industry is no longer being rewarded for incremental innovation, metoo products and selling the most pills. To gain insight, pm360 asked 12 experts the following questions. The changing landscape of physician interactions pharma. A glimpse into the future marketers are expected to take full control of the customer experience in the coming years the economist intelligence unit asked 499 one cant help but. What impact will this evolution have on pharmaceutical sales jobs. In this generation more pharmaceutical companies are using social media sites or. Regeneron has shared high hopes for its two candidates in the fight against covid19 on the first day of the fourday eyeforpharma. Digital technology is enabling new biopharma value propositions. Generic drug providers excel in producing and delivering drugs at a low cost and as a result are fully backward integrated. The future of pharma marketing one to five years out. The future of highly compliant, efficient equipment.
Mckinsey recently spoke to industry leaders in oncology research and cancer care to ask about their vision of the future for oncology. Originators, the classical pharma model, focus on financing the development and marketing of new drugs. Propelling access and acceptance, realising true potential. This connectivity is both within and beyond company walls. Preparing for biopharma marketing in 2020 and beyond who is. Ftc delays novartis sandoz deal with aurobindo into 2020.
How digital technology is enabling patient centricity. Powerful forces are transforming healthcare from a providerdriven marketplace to a patientcentric health ecosystem. Marketing the future is the third in this series of papers on the future of the pharmaceutical industry published by pricewaterhousecoopers. The primarycare sector is expanding and becoming more regimented, as.
446 785 960 541 1269 673 1370 597 1271 264 1180 255 883 779 1471 359 895 533 1374 1237 344 105 1299 933 353 1408 410 1147 336 794 371 799 1159